0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetes Software Market Insights, Forecast to 2028
Published Date: April 2022
|
Report Code: QYRE-Auto-9F2714
Home | Market Reports | Health | Health Conditions | Endocrine Conditions
Global Diabetes Software Market Insights Forecast to 2028

Global Diabetes Software Market Insights, Forecast to 2028

Code: QYRE-Auto-9F2714
Report
April 2022
110 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Diabetes software can include aggregate and analytical views of diabetes data. These views include:
– Calendar views that display glucose trends and compare them to patient’s insulin intake.
– Modal day views that display glucose trends and compare them to insulin intake on the same day of the week over time.
– Listing of contextual and lifestyle data such as patient’s carb intake.
– Insulin data that includes pie charts showing the ratio of basal to bolus rates.
– General data tables that show average blood glucose rates bucketed into different time periods
– And more.
More advanced diabetes software applications can include predictive insights. These insights can provide patients with alerts regarding their propensity to experience hyperglycemia or hypoglycemia events under certain conditions.
Market Analysis and Insights: Global Diabetes Software Market

The global Diabetes Software market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, For Smartphones accounting for % of the Diabetes Software global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Type 1 Diabetes segment is altered to an % CAGR throughout this forecast period.
China Diabetes Software market size is valued at US$ million in 2021, while the North America and Europe Diabetes Software are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Diabetes Software landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Software market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Software market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Software market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Software market.
Global Diabetes Software Scope and Market Size
Diabetes Software market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Diabetes Software market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

For Smartphones
For Tablet PC
Web-based

Segment by Application

Type 1 Diabetes
Type 2 Diabetes

BY COMPANY

Glooko
Accu-Chek (Roche)
Tidepool
LifeScan, Inc (Platinum Equity)
Pharmaco Diabetes
Ascensia Diabetes Care Holdings AG
Diabeto Medtech India Pvt. Ltd
Abbott Diabetes Care
Acon Diabetes Care International
BIONIME
Custo med
Dexcom
Dottli
GlucoMe
MyLife
Nova
Tandem Diabetes Care
Trividia Health

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Software Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 For Smartphones
1.2.3 For Tablet PC
1.2.4 Web-based
1.3 Market by Application
1.3.1 Global Diabetes Software Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Software Market Perspective (2017-2028)
2.2 Diabetes Software Growth Trends by Region
2.2.1 Diabetes Software Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Diabetes Software Historic Market Size by Region (2017-2022)
2.2.3 Diabetes Software Forecasted Market Size by Region (2023-2028)
2.3 Diabetes Software Market Dynamics
2.3.1 Diabetes Software Industry Trends
2.3.2 Diabetes Software Market Drivers
2.3.3 Diabetes Software Market Challenges
2.3.4 Diabetes Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Software Players by Revenue
3.1.1 Global Top Diabetes Software Players by Revenue (2017-2022)
3.1.2 Global Diabetes Software Revenue Market Share by Players (2017-2022)
3.2 Global Diabetes Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Software Revenue
3.4 Global Diabetes Software Market Concentration Ratio
3.4.1 Global Diabetes Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Software Revenue in 2021
3.5 Diabetes Software Key Players Head office and Area Served
3.6 Key Players Diabetes Software Product Solution and Service
3.7 Date of Enter into Diabetes Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Software Breakdown Data by Type
4.1 Global Diabetes Software Historic Market Size by Type (2017-2022)
4.2 Global Diabetes Software Forecasted Market Size by Type (2023-2028)
5 Diabetes Software Breakdown Data by Application
5.1 Global Diabetes Software Historic Market Size by Application (2017-2022)
5.2 Global Diabetes Software Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Diabetes Software Market Size (2017-2028)
6.2 North America Diabetes Software Market Size by Type
6.2.1 North America Diabetes Software Market Size by Type (2017-2022)
6.2.2 North America Diabetes Software Market Size by Type (2023-2028)
6.2.3 North America Diabetes Software Market Share by Type (2017-2028)
6.3 North America Diabetes Software Market Size by Application
6.3.1 North America Diabetes Software Market Size by Application (2017-2022)
6.3.2 North America Diabetes Software Market Size by Application (2023-2028)
6.3.3 North America Diabetes Software Market Share by Application (2017-2028)
6.4 North America Diabetes Software Market Size by Country
6.4.1 North America Diabetes Software Market Size by Country (2017-2022)
6.4.2 North America Diabetes Software Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Diabetes Software Market Size (2017-2028)
7.2 Europe Diabetes Software Market Size by Type
7.2.1 Europe Diabetes Software Market Size by Type (2017-2022)
7.2.2 Europe Diabetes Software Market Size by Type (2023-2028)
7.2.3 Europe Diabetes Software Market Share by Type (2017-2028)
7.3 Europe Diabetes Software Market Size by Application
7.3.1 Europe Diabetes Software Market Size by Application (2017-2022)
7.3.2 Europe Diabetes Software Market Size by Application (2023-2028)
7.3.3 Europe Diabetes Software Market Share by Application (2017-2028)
7.4 Europe Diabetes Software Market Size by Country
7.4.1 Europe Diabetes Software Market Size by Country (2017-2022)
7.4.2 Europe Diabetes Software Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Software Market Size (2017-2028)
8.2 Asia-Pacific Diabetes Software Market Size by Type
8.2.1 Asia-Pacific Diabetes Software Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Diabetes Software Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Diabetes Software Market Share by Type (2017-2028)
8.3 Asia-Pacific Diabetes Software Market Size by Application
8.3.1 Asia-Pacific Diabetes Software Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Diabetes Software Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Diabetes Software Market Share by Application (2017-2028)
8.4 Asia-Pacific Diabetes Software Market Size by Region
8.4.1 Asia-Pacific Diabetes Software Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Diabetes Software Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetes Software Market Size (2017-2028)
9.2 Latin America Diabetes Software Market Size by Type
9.2.1 Latin America Diabetes Software Market Size by Type (2017-2022)
9.2.2 Latin America Diabetes Software Market Size by Type (2023-2028)
9.2.3 Latin America Diabetes Software Market Share by Type (2017-2028)
9.3 Latin America Diabetes Software Market Size by Application
9.3.1 Latin America Diabetes Software Market Size by Application (2017-2022)
9.3.2 Latin America Diabetes Software Market Size by Application (2023-2028)
9.3.3 Latin America Diabetes Software Market Share by Application (2017-2028)
9.4 Latin America Diabetes Software Market Size by Country
9.4.1 Latin America Diabetes Software Market Size by Country (2017-2022)
9.4.2 Latin America Diabetes Software Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Software Market Size (2017-2028)
10.2 Middle East & Africa Diabetes Software Market Size by Type
10.2.1 Middle East & Africa Diabetes Software Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Diabetes Software Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Diabetes Software Market Share by Type (2017-2028)
10.3 Middle East & Africa Diabetes Software Market Size by Application
10.3.1 Middle East & Africa Diabetes Software Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Diabetes Software Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Diabetes Software Market Share by Application (2017-2028)
10.4 Middle East & Africa Diabetes Software Market Size by Country
10.4.1 Middle East & Africa Diabetes Software Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Diabetes Software Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Glooko
11.1.1 Glooko Company Details
11.1.2 Glooko Business Overview
11.1.3 Glooko Diabetes Software Introduction
11.1.4 Glooko Revenue in Diabetes Software Business (2017-2022)
11.1.5 Glooko Recent Developments
11.2 Accu-Chek (Roche)
11.2.1 Accu-Chek (Roche) Company Details
11.2.2 Accu-Chek (Roche) Business Overview
11.2.3 Accu-Chek (Roche) Diabetes Software Introduction
11.2.4 Accu-Chek (Roche) Revenue in Diabetes Software Business (2017-2022)
11.2.5 Accu-Chek (Roche) Recent Developments
11.3 Tidepool
11.3.1 Tidepool Company Details
11.3.2 Tidepool Business Overview
11.3.3 Tidepool Diabetes Software Introduction
11.3.4 Tidepool Revenue in Diabetes Software Business (2017-2022)
11.3.5 Tidepool Recent Developments
11.4 LifeScan, Inc (Platinum Equity)
11.4.1 LifeScan, Inc (Platinum Equity) Company Details
11.4.2 LifeScan, Inc (Platinum Equity) Business Overview
11.4.3 LifeScan, Inc (Platinum Equity) Diabetes Software Introduction
11.4.4 LifeScan, Inc (Platinum Equity) Revenue in Diabetes Software Business (2017-2022)
11.4.5 LifeScan, Inc (Platinum Equity) Recent Developments
11.5 Pharmaco Diabetes
11.5.1 Pharmaco Diabetes Company Details
11.5.2 Pharmaco Diabetes Business Overview
11.5.3 Pharmaco Diabetes Diabetes Software Introduction
11.5.4 Pharmaco Diabetes Revenue in Diabetes Software Business (2017-2022)
11.5.5 Pharmaco Diabetes Recent Developments
11.6 Ascensia Diabetes Care Holdings AG
11.6.1 Ascensia Diabetes Care Holdings AG Company Details
11.6.2 Ascensia Diabetes Care Holdings AG Business Overview
11.6.3 Ascensia Diabetes Care Holdings AG Diabetes Software Introduction
11.6.4 Ascensia Diabetes Care Holdings AG Revenue in Diabetes Software Business (2017-2022)
11.6.5 Ascensia Diabetes Care Holdings AG Recent Developments
11.7 Diabeto Medtech India Pvt. Ltd
11.7.1 Diabeto Medtech India Pvt. Ltd Company Details
11.7.2 Diabeto Medtech India Pvt. Ltd Business Overview
11.7.3 Diabeto Medtech India Pvt. Ltd Diabetes Software Introduction
11.7.4 Diabeto Medtech India Pvt. Ltd Revenue in Diabetes Software Business (2017-2022)
11.7.5 Diabeto Medtech India Pvt. Ltd Recent Developments
11.8 Abbott Diabetes Care
11.8.1 Abbott Diabetes Care Company Details
11.8.2 Abbott Diabetes Care Business Overview
11.8.3 Abbott Diabetes Care Diabetes Software Introduction
11.8.4 Abbott Diabetes Care Revenue in Diabetes Software Business (2017-2022)
11.8.5 Abbott Diabetes Care Recent Developments
11.9 Acon Diabetes Care International
11.9.1 Acon Diabetes Care International Company Details
11.9.2 Acon Diabetes Care International Business Overview
11.9.3 Acon Diabetes Care International Diabetes Software Introduction
11.9.4 Acon Diabetes Care International Revenue in Diabetes Software Business (2017-2022)
11.9.5 Acon Diabetes Care International Recent Developments
11.10 BIONIME
11.10.1 BIONIME Company Details
11.10.2 BIONIME Business Overview
11.10.3 BIONIME Diabetes Software Introduction
11.10.4 BIONIME Revenue in Diabetes Software Business (2017-2022)
11.10.5 BIONIME Recent Developments
11.11 Custo med
11.11.1 Custo med Company Details
11.11.2 Custo med Business Overview
11.11.3 Custo med Diabetes Software Introduction
11.11.4 Custo med Revenue in Diabetes Software Business (2017-2022)
11.11.5 Custo med Recent Developments
11.12 Dexcom
11.12.1 Dexcom Company Details
11.12.2 Dexcom Business Overview
11.12.3 Dexcom Diabetes Software Introduction
11.12.4 Dexcom Revenue in Diabetes Software Business (2017-2022)
11.12.5 Dexcom Recent Developments
11.13 Dottli
11.13.1 Dottli Company Details
11.13.2 Dottli Business Overview
11.13.3 Dottli Diabetes Software Introduction
11.13.4 Dottli Revenue in Diabetes Software Business (2017-2022)
11.13.5 Dottli Recent Developments
11.14 GlucoMe
11.14.1 GlucoMe Company Details
11.14.2 GlucoMe Business Overview
11.14.3 GlucoMe Diabetes Software Introduction
11.14.4 GlucoMe Revenue in Diabetes Software Business (2017-2022)
11.14.5 GlucoMe Recent Developments
11.15 MyLife
11.15.1 MyLife Company Details
11.15.2 MyLife Business Overview
11.15.3 MyLife Diabetes Software Introduction
11.15.4 MyLife Revenue in Diabetes Software Business (2017-2022)
11.15.5 MyLife Recent Developments
11.16 Nova
11.16.1 Nova Company Details
11.16.2 Nova Business Overview
11.16.3 Nova Diabetes Software Introduction
11.16.4 Nova Revenue in Diabetes Software Business (2017-2022)
11.16.5 Nova Recent Developments
11.17 Tandem Diabetes Care
11.17.1 Tandem Diabetes Care Company Details
11.17.2 Tandem Diabetes Care Business Overview
11.17.3 Tandem Diabetes Care Diabetes Software Introduction
11.17.4 Tandem Diabetes Care Revenue in Diabetes Software Business (2017-2022)
11.17.5 Tandem Diabetes Care Recent Developments
11.18 Trividia Health
11.18.1 Trividia Health Company Details
11.18.2 Trividia Health Business Overview
11.18.3 Trividia Health Diabetes Software Introduction
11.18.4 Trividia Health Revenue in Diabetes Software Business (2017-2022)
11.18.5 Trividia Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Diabetes Software Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of For Smartphones
    Table 3. Key Players of For Tablet PC
    Table 4. Key Players of Web-based
    Table 5. Global Diabetes Software Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Diabetes Software Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Diabetes Software Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Diabetes Software Market Share by Region (2017-2022)
    Table 9. Global Diabetes Software Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Diabetes Software Market Share by Region (2023-2028)
    Table 11. Diabetes Software Market Trends
    Table 12. Diabetes Software Market Drivers
    Table 13. Diabetes Software Market Challenges
    Table 14. Diabetes Software Market Restraints
    Table 15. Global Diabetes Software Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Diabetes Software Revenue Share by Players (2017-2022)
    Table 17. Global Top Diabetes Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Software as of 2021)
    Table 18. Ranking of Global Top Diabetes Software Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Diabetes Software Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Diabetes Software Product Solution and Service
    Table 22. Date of Enter into Diabetes Software Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Diabetes Software Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Diabetes Software Revenue Market Share by Type (2017-2022)
    Table 26. Global Diabetes Software Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Diabetes Software Revenue Market Share by Type (2023-2028)
    Table 28. Global Diabetes Software Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Diabetes Software Revenue Share by Application (2017-2022)
    Table 30. Global Diabetes Software Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Diabetes Software Revenue Share by Application (2023-2028)
    Table 32. North America Diabetes Software Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Diabetes Software Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Diabetes Software Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Diabetes Software Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Diabetes Software Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Diabetes Software Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Diabetes Software Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Diabetes Software Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Diabetes Software Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Diabetes Software Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Diabetes Software Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Diabetes Software Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Diabetes Software Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Diabetes Software Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Diabetes Software Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Diabetes Software Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Diabetes Software Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Diabetes Software Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Diabetes Software Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Diabetes Software Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Diabetes Software Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Diabetes Software Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Diabetes Software Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Diabetes Software Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Diabetes Software Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Diabetes Software Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Diabetes Software Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Diabetes Software Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Diabetes Software Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Diabetes Software Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Glooko Company Details
    Table 63. Glooko Business Overview
    Table 64. Glooko Diabetes Software Product
    Table 65. Glooko Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 66. Glooko Recent Developments
    Table 67. Accu-Chek (Roche) Company Details
    Table 68. Accu-Chek (Roche) Business Overview
    Table 69. Accu-Chek (Roche) Diabetes Software Product
    Table 70. Accu-Chek (Roche) Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 71. Accu-Chek (Roche) Recent Developments
    Table 72. Tidepool Company Details
    Table 73. Tidepool Business Overview
    Table 74. Tidepool Diabetes Software Product
    Table 75. Tidepool Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 76. Tidepool Recent Developments
    Table 77. LifeScan, Inc (Platinum Equity) Company Details
    Table 78. LifeScan, Inc (Platinum Equity) Business Overview
    Table 79. LifeScan, Inc (Platinum Equity) Diabetes Software Product
    Table 80. LifeScan, Inc (Platinum Equity) Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 81. LifeScan, Inc (Platinum Equity) Recent Developments
    Table 82. Pharmaco Diabetes Company Details
    Table 83. Pharmaco Diabetes Business Overview
    Table 84. Pharmaco Diabetes Diabetes Software Product
    Table 85. Pharmaco Diabetes Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 86. Pharmaco Diabetes Recent Developments
    Table 87. Ascensia Diabetes Care Holdings AG Company Details
    Table 88. Ascensia Diabetes Care Holdings AG Business Overview
    Table 89. Ascensia Diabetes Care Holdings AG Diabetes Software Product
    Table 90. Ascensia Diabetes Care Holdings AG Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 91. Ascensia Diabetes Care Holdings AG Recent Developments
    Table 92. Diabeto Medtech India Pvt. Ltd Company Details
    Table 93. Diabeto Medtech India Pvt. Ltd Business Overview
    Table 94. Diabeto Medtech India Pvt. Ltd Diabetes Software Product
    Table 95. Diabeto Medtech India Pvt. Ltd Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 96. Diabeto Medtech India Pvt. Ltd Recent Developments
    Table 97. Abbott Diabetes Care Company Details
    Table 98. Abbott Diabetes Care Business Overview
    Table 99. Abbott Diabetes Care Diabetes Software Product
    Table 100. Abbott Diabetes Care Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 101. Abbott Diabetes Care Recent Developments
    Table 102. Acon Diabetes Care International Company Details
    Table 103. Acon Diabetes Care International Business Overview
    Table 104. Acon Diabetes Care International Diabetes Software Product
    Table 105. Acon Diabetes Care International Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 106. Acon Diabetes Care International Recent Developments
    Table 107. BIONIME Company Details
    Table 108. BIONIME Business Overview
    Table 109. BIONIME Diabetes Software Product
    Table 110. BIONIME Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 111. BIONIME Recent Developments
    Table 112. Custo med Company Details
    Table 113. Custo med Business Overview
    Table 114. Custo med Diabetes Software Product
    Table 115. Custo med Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 116. Custo med Recent Developments
    Table 117. Dexcom Company Details
    Table 118. Dexcom Business Overview
    Table 119. Dexcom Diabetes Software Product
    Table 120. Dexcom Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 121. Dexcom Recent Developments
    Table 122. Dottli Company Details
    Table 123. Dottli Business Overview
    Table 124. Dottli Diabetes Software Product
    Table 125. Dottli Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 126. Dottli Recent Developments
    Table 127. GlucoMe Company Details
    Table 128. GlucoMe Business Overview
    Table 129. GlucoMe Diabetes Software Product
    Table 130. GlucoMe Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 131. GlucoMe Recent Developments
    Table 132. MyLife Company Details
    Table 133. MyLife Business Overview
    Table 134. MyLife Diabetes Software Product
    Table 135. MyLife Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 136. MyLife Recent Developments
    Table 137. Nova Company Details
    Table 138. Nova Business Overview
    Table 139. Nova Diabetes Software Product
    Table 140. Nova Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 141. Nova Recent Developments
    Table 142. Tandem Diabetes Care Company Details
    Table 143. Tandem Diabetes Care Business Overview
    Table 144. Tandem Diabetes Care Diabetes Software Product
    Table 145. Tandem Diabetes Care Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 146. Tandem Diabetes Care Recent Developments
    Table 147. Trividia Health Company Details
    Table 148. Trividia Health Business Overview
    Table 149. Trividia Health Diabetes Software Product
    Table 150. Trividia Health Revenue in Diabetes Software Business (2017-2022) & (US$ Million)
    Table 151. Trividia Health Recent Developments
    Table 152. Research Programs/Design for This Report
    Table 153. Key Data Information from Secondary Sources
    Table 154. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diabetes Software Market Share by Type: 2021 VS 2028
    Figure 2. For Smartphones Features
    Figure 3. For Tablet PC Features
    Figure 4. Web-based Features
    Figure 5. Global Diabetes Software Market Share by Application: 2021 VS 2028
    Figure 6. Type 1 Diabetes Case Studies
    Figure 7. Type 2 Diabetes Case Studies
    Figure 8. Diabetes Software Report Years Considered
    Figure 9. Global Diabetes Software Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Diabetes Software Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Diabetes Software Market Share by Region: 2021 VS 2028
    Figure 12. Global Diabetes Software Market Share by Players in 2021
    Figure 13. Global Top Diabetes Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Software as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Diabetes Software Revenue in 2021
    Figure 15. North America Diabetes Software Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Diabetes Software Market Size Market Share by Type (2017-2028)
    Figure 17. North America Diabetes Software Market Size Market Share by Application (2017-2028)
    Figure 18. North America Diabetes Software Market Size Share by Country (2017-2028)
    Figure 19. United States Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Diabetes Software Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Diabetes Software Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Diabetes Software Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Diabetes Software Market Size Share by Country (2017-2028)
    Figure 25. Germany Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Diabetes Software Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Diabetes Software Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Diabetes Software Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Diabetes Software Market Size Share by Region (2017-2028)
    Figure 35. China Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Diabetes Software Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Diabetes Software Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Diabetes Software Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Diabetes Software Market Size Share by Country (2017-2028)
    Figure 45. Mexico Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Diabetes Software Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Diabetes Software Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Diabetes Software Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Diabetes Software Market Size Share by Country (2017-2028)
    Figure 51. Turkey Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Diabetes Software Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Glooko Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 55. Accu-Chek (Roche) Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 56. Tidepool Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 57. LifeScan, Inc (Platinum Equity) Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 58. Pharmaco Diabetes Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 59. Ascensia Diabetes Care Holdings AG Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 60. Diabeto Medtech India Pvt. Ltd Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 61. Abbott Diabetes Care Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 62. Acon Diabetes Care International Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 63. BIONIME Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 64. Custo med Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 65. Dexcom Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 66. Dottli Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 67. GlucoMe Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 68. MyLife Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 69. Nova Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 70. Tandem Diabetes Care Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 71. Trividia Health Revenue Growth Rate in Diabetes Software Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global and United States Insulin Drug Delivery Devices Market Report Forecast 2022 2028
Global and United States Insulin Drug Delivery Devices Market Report & Forecast 2022-2028

Insulin delivery devices that are currently available for the administration of insulin include syringes insulin infusion pumps jet injectors and pens.Market Analysis and Insights Global and United States Insulin Drug Delivery Devices MarketThis report focuses on global and United States Insulin Drug Delivery Devices market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Insulin Drug Delivery Devices market size is estimated to be worth US 14710 million in 2022 and is forecast to a readjusted size of US 19310 million by 2028 with a CAGR of 4.6 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-37X10341
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global Diabetes Software Market Insights Forecast to 2028
Global Diabetes Software Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-9F2714
Fri Apr 08 00:00:00 UTC 2022

Add to Cart

United States Dipeptidyl Peptidase IV DPP IV Inhibitors Market Report Forecast 2021 2027
Global and United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-5X8306
Fri Apr 08 00:00:00 UTC 2022

Add to Cart

United States Disposable Insulin Pumps Market Report Forecast 2021 2027
Global and United States Disposable Insulin Pumps Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-33T8000
Fri Apr 08 00:00:00 UTC 2022

Add to Cart